WAM
PFE icon

Wolverine Asset Management’s Pfizer PFE Stock Holding History

Wolverine Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-77,136
Closed -$1.9M – 1778
2025
Q2 		$1.87M Buy
77,136
+31,990
+71% +$746K 0.02% 546
2025
Q1 		$1.14M Buy
45,146
+32,767
+265% +$857K 0.01% 647
2024
Q4 		$328K Sell
12,379
-7,585
-38% -$206K ﹤0.01% 939
2024
Q3 		$578K Buy
+19,964
New +$582K 0.01% 829
2024
Q2 		– Sell
-11,731
Closed -$323K – 1753
2024
Q1 		$326K Sell
11,731
-139,232
-92% -$3.86M ﹤0.01% 893
2023
Q4 		$4.35M Buy
150,963
+95,162
+171% +$2.88M 0.04% 371
2023
Q3 		$1.85M Buy
55,801
+13,889
+33% +$491K 0.02% 561
2023
Q2 		$1.54M Sell
41,912
-15,972
-28% -$622K 0.02% 564
2023
Q1 		$2.36M Buy
57,884
+51,686
+834% +$2.23M 0.03% 481
2022
Q4 		$318K Sell
6,198
-3,727
-38% -$179K ﹤0.01% 1042
2022
Q3 		$434K Buy
+9,925
New +$482K ﹤0.01% 1066
2021
Q3 		– Sell
-10,511
Closed -$411K – 2260
2021
Q2 		$411K Buy
+10,511
New +$409K ﹤0.01% 979
2021
Q1 		– Sell
-29,595
Closed -$1.09M – 2206
2020
Q4 		$1.09M Buy
29,595
+7,752
+35% +$284K 0.01% 625
2020
Q3 		$760K Buy
21,843
+3,976
+22% +$139K 0.01% 628
2020
Q2 		$554K Buy
+17,867
New +$607K 0.01% 693
2019
Q4 		– Sell
-1,729
Closed -$58K – 1488
2019
Q3 		$58K Sell
1,729
-22,509
-93% -$819K ﹤0.01% 1196
2019
Q2 		$996K Buy
24,238
+22,702
+1,478% +$901K 0.01% 652
2019
Q1 		$61K Sell
1,536
-6,033
-80% -$242K ﹤0.01% 1165
2018
Q4 		$313K Buy
+7,569
New +$314K ﹤0.01% 1151
2018
Q3 		– Sell
-67,166
Closed -$2.31M – 1607
2018
Q2 		$2.31M Sell
67,166
-44,268
-40% -$1.51M 0.03% 481
2018
Q1 		$3.75M Buy
111,434
+25,282
+29% +$869K 0.05% 322
2017
Q4 		$2.96M Sell
86,152
-14,135
-14% -$482K 0.03% 402
2017
Q3 		$3.4M Buy
100,287
+70,564
+237% +$2.27M 0.04% 336
2017
Q2 		$947K Buy
29,723
+13,175
+80% +$415K 0.01% 627
2017
Q1 		$537K Buy
16,548
+7,800
+89% +$246K 0.01% 678
2016
Q4 		$269K Buy
+8,748
New +$267K ﹤0.01% 794
2016
Q1 		– Sell
-786,844
Closed -$22.5M – 1540
2015
Q4 		$24.1M Buy
786,844
+779,615
+10,785% +$24.5M 0.52% 51
2015
Q3 		$215K Sell
7,229
-36,785
-84% -$1.18M 0.01% 891
2015
Q2 		$1.4M Buy
44,014
+22,134
+101% +$721K 0.03% 392
2015
Q1 		$722K Buy
+21,880
New +$696K 0.01% 520
2014
Q4 		– Sell
-51,599
Closed -$1.48M – 2437
2014
Q3 		$1.45M Buy
51,599
+721
+1% +$20.2K 0.03% 367
2014
Q2 		$1.43M Sell
50,878
-33,504
-40% -$955K 0.03% 324
2014
Q1 		$2.57M Sell
84,382
-23,220
-22% -$692K 0.06% 239
2013
Q4 		$3.13M Buy
107,602
+26,877
+33% +$782K 0.06% 241
2013
Q3 		$2.2M Sell
80,725
-309,378
-79% -$8.42M 0.05% 309
2013
Q2 		$10.4M Buy
+390,103
New +$10.8M 0.27% 88

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Wolverine Asset Management's PFE Position: Q3 2025 in Review

Wolverine Asset Management sold out of Pfizer (PFE) in Q3 2025, closing a stake of 77,136 shares — an estimated $1.9M sold.

Wolverine Asset Management first reported a position in PFE in Q2 2013 and held it in 36 quarters. The position peaked at $24.1M in Q4 2015. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Wolverine Asset Management reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Wolverine Asset Management sold 77,136 Pfizer shares in Q3 2025, an estimated $1.9M.
  • Wolverine Asset Management first reported a position in Pfizer in Q2 2013 and held it in 36 quarters.
  • Wolverine Asset Management's Pfizer position peaked at $24.1M in Q4 2015.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Wolverine Asset Management's 13F filing for Q3 2025, filed 28 Oct 2025.